301 related articles for article (PubMed ID: 15648440)
1. Crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil-cytoplasmic antibodies: first report on the efficacy of primary anti-TNF-alpha treatment.
Zaenker M; Arbach O; Helmchen U; Glorius P; Ludewig S; Braasch E
Int J Tissue React; 2004; 26(3-4):85-92. PubMed ID: 15648440
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase antineutrophil cytoplasmic antibody-positive necrotizing crescentic glomerulonephritis and membranous glomerulonephropathy.
Taniguchi Y; Yorioka N; Kumagai J; Ito T; Yamakido M; Taguchi T
Clin Nephrol; 1999 Oct; 52(4):253-5. PubMed ID: 10543328
[TBL] [Abstract][Full Text] [Related]
3. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
4. [ANCA-associated vasculitis].
Sinico RA; Sabadini E; Boeri R; Radice A
G Ital Nefrol; 2002; 19(2):125-36. PubMed ID: 12195410
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases.
Feldmann M; Pusey CD
J Am Soc Nephrol; 2006 May; 17(5):1243-52. PubMed ID: 16624928
[TBL] [Abstract][Full Text] [Related]
6. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
[TBL] [Abstract][Full Text] [Related]
7. Treatment of ANCA-associated systemic vasculitis.
Belmont HM
Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
9. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity.
Nasr SH; D'Agati VD; Park HR; Sterman PL; Goyzueta JD; Dressler RM; Hazlett SM; Pursell RN; Caputo C; Markowitz GS
Clin J Am Soc Nephrol; 2008 May; 3(3):682-90. PubMed ID: 18287252
[TBL] [Abstract][Full Text] [Related]
10. Serum myeloperoxidase and serum cytokines in anti-myeloperoxidase antibody-associated glomerulonephritis.
Arimura Y; Minoshima S; Kamiya Y; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Sasaki T; Suzuki K
Clin Nephrol; 1993 Nov; 40(5):256-64. PubMed ID: 8281714
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in a very elderly patient with generalized vasculitis at autopsy.
Nakamura C; Yorioka N; Nakanishi S; Naito T; Sugimoto N; Kanahara K; Mano M; Katayama S; Ishikawa K
Hiroshima J Med Sci; 1997 Sep; 46(3):99-104. PubMed ID: 9353970
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis.
Kokolina E; Alexopoulos E; Dimitriadis C; Vainas A; Giamalis P; Papagianni A; Ekonomidou D; Memmos D
Ann N Y Acad Sci; 2005 Jun; 1051():597-605. PubMed ID: 16127000
[TBL] [Abstract][Full Text] [Related]
13. [Crescentic glomerulonephritis with anti neutrophil cytoplasmic antibody in children. Cases report].
Cavagnaro F; Talesnik E
Rev Med Chil; 1999 Aug; 127(8):970-6. PubMed ID: 10752259
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha bioactivity-inhibiting therapy in ANCA-associated vasculitis: clinical and experimental considerations.
Huugen D; Tervaert JW; Heeringa P
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1100-7. PubMed ID: 17699331
[TBL] [Abstract][Full Text] [Related]
15. Development of anti-glomerular basement membrane disease after remission from perinuclear ANCA-associated glomerulonephritis in a patient with HLA susceptibility.
O'Connor K; Fulcher D; Phoon RK
Am J Kidney Dis; 2010 Mar; 55(3):566-9. PubMed ID: 19733946
[TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibody-associated glomerulonephritis in Taiwanese.
Hung PH; Chiang WC; Chen YM; Lin SL; Lin WC; Tsai TJ; Chen WY
Nephrology (Carlton); 2004 Oct; 9(5):297-303. PubMed ID: 15504142
[TBL] [Abstract][Full Text] [Related]
17. Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α.
Hirohama D; Hoshino J; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Takemoto F; Ubara Y; Hara S; Ohashi K; Takaichi K
Mod Rheumatol; 2010 Dec; 20(6):602-5. PubMed ID: 20680377
[TBL] [Abstract][Full Text] [Related]
18. Glomerular lesions in patients with Churg-Strauss syndrome and the anti-myeloperoxidase antibody.
Kikuchi Y; Ikehata N; Tajima O; Yoshizawa N; Miura S
Clin Nephrol; 2001 Jun; 55(6):429-35. PubMed ID: 11434353
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of anti-TNF-alpha antibodies in an experimental model of anti-neutrophil cytoplasm antibody-associated systemic vasculitis.
Little MA; Bhangal G; Smyth CL; Nakada MT; Cook HT; Nourshargh S; Pusey CD
J Am Soc Nephrol; 2006 Jan; 17(1):160-9. PubMed ID: 16306166
[TBL] [Abstract][Full Text] [Related]
20. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
